Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-6-1
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Americas, http://linkedlifedata.com/resource/pubmed/keyword/Biology, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Importation, http://linkedlifedata.com/resource/pubmed/keyword/Developed Countries, http://linkedlifedata.com/resource/pubmed/keyword/Endocrine System, http://linkedlifedata.com/resource/pubmed/keyword/Europe, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning Program..., http://linkedlifedata.com/resource/pubmed/keyword/Family Planning Programs, http://linkedlifedata.com/resource/pubmed/keyword/France, http://linkedlifedata.com/resource/pubmed/keyword/Government Agencies, http://linkedlifedata.com/resource/pubmed/keyword/Hormone Antagonists, http://linkedlifedata.com/resource/pubmed/keyword/Hormones, http://linkedlifedata.com/resource/pubmed/keyword/Knowledge, http://linkedlifedata.com/resource/pubmed/keyword/Mediterranean Countries, http://linkedlifedata.com/resource/pubmed/keyword/North America, http://linkedlifedata.com/resource/pubmed/keyword/Northern America, http://linkedlifedata.com/resource/pubmed/keyword/Organizations, http://linkedlifedata.com/resource/pubmed/keyword/Physiology, http://linkedlifedata.com/resource/pubmed/keyword/Product Approval, http://linkedlifedata.com/resource/pubmed/keyword/Ru-486--legal aspects, http://linkedlifedata.com/resource/pubmed/keyword/United States, http://linkedlifedata.com/resource/pubmed/keyword/Usfda, http://linkedlifedata.com/resource/pubmed/keyword/Usphs, http://linkedlifedata.com/resource/pubmed/keyword/Western Europe
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
J
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1017-8538
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
PIP
pubmed:authorsComplete
Y
pubmed:pagination
18-9
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:12288950-Americas, pubmed-meshheading:12288950-Biology, pubmed-meshheading:12288950-Commerce, pubmed-meshheading:12288950-Consumer Product Safety, pubmed-meshheading:12288950-Developed Countries, pubmed-meshheading:12288950-Endocrine System, pubmed-meshheading:12288950-Europe, pubmed-meshheading:12288950-Family Planning Services, pubmed-meshheading:12288950-France, pubmed-meshheading:12288950-Government Agencies, pubmed-meshheading:12288950-Health Planning, pubmed-meshheading:12288950-Hormone Antagonists, pubmed-meshheading:12288950-Hormones, pubmed-meshheading:12288950-Knowledge, pubmed-meshheading:12288950-Mifepristone, pubmed-meshheading:12288950-North America, pubmed-meshheading:12288950-Organization and Administration, pubmed-meshheading:12288950-Organizations, pubmed-meshheading:12288950-Physiology, pubmed-meshheading:12288950-United States, pubmed-meshheading:12288950-United States Food and Drug Administration, pubmed-meshheading:12288950-United States Public Health Service
pubmed:year
1993
pubmed:articleTitle
Introduction of RU 486 in the USA: obstacles and opportunities.
pubmed:publicationType
Journal Article